FSH Fast Test Kit
(Immunofluorescence Assay)
Intended Use
FSH Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of FSH in human serum and plasma. FSH testing is used for women suspected of having polycystic ovary syndrome, and in individuals undergoing evaluation for infertility, also used for evaluation of individuals with suspected pituitary disorders or diseases of the ovaries.
About FSH
Follicle stimulating hormone (FSH) is one of the hormones essential to pubertal development and the function of women's ovaries and men's testes. Like other glycoproteins, such as LH, TSH and HCG, FSH consists of subunits designated as alpha and beta. Hormones of this type have alpha subunits that are very similarly structurally, therefore the biological and immunological properties of each are dependent on the unique beta subunit.
In women, this hormone stimulates the growth of ovarian follicles in the ovary before the release of an egg from one follicle at ovulation. FSH levels are elevated after menopause, castration and in premature ovarian failure. In men, FSH stimulates seminiferous tubule testicular growth, and is involved in the early stages of spermatogenesis.
Specifications
|
Test Item |
Sample Types |
Methodology |
Storage Condition |
|
FSH |
S/P |
Immunofluorescence Assay |
4-30℃ |
|
Detection Range |
Test Time |
Cut-off Value |
Shelf Life |
|
0.2~150.0 mIU/mL |
15 min |
Refer to User Manual |
24 months |
Applicable Device
Getein 1100 Immunofluorescence Quantitative Analyzer
Getein 1160 Immunofluorescence Quantitative Analyzer
Getein 1180 Immunofluorescence Quantitative Analyzer
Getein 1200 Immunofluorescence Quantitative Analyzer
Getein 1600 Immunofluorescence Quantitative Analyzer
Clinical Application
1. As an aid in the diagnosis of Oligospermic.
2. As an aid in the diagnosis of primary testicular failure and Kinefelter Syndrome.
3. As an aid in the treatment of anovulatory infertility.
4. As a useful marker in the study of pituitary disease, classification of pituitary tumors and in the differential diagnosis of primary and metastatic tumors of the pituitary.
